Initiation of Drug Treatment
Treating prediabetes is an essential part of reducing the risk of cardiovascular disease and the risk of developing type 2 diabetes. Type 2 diabetes can be delayed with early intervention. Glucobay® (Acarbose) is an established therapy for type 2 diabetes patients, and a treatment increasingly used in individuals with prediabetes. Glucobay® is, therefore, a suitable first-line pharmacotherapy for individuals at all stages of the dysglycaemia disease continuum.
Primary care is the natural setting for prediabetes screening programmes and for the administration of early therapy.
The majority of prediabetic subjects are largely asymptomatic, and may only be identified when reporting to their primary care physician for an unrelated or routine visit.
Several trials (e.g., STOP-NIDDM) provide evidence that pharmacotherapy can prevent the development of diabetes.
Glucobay® is currently the only oral antidiabetes agent approved for prediabetes, based on proven clinical benefits.
Glucobay® directly reduces postprandial hyperglycaemia when taken with meals and can be used throughout the dysglycaemia disease continuum. The early use of Glucobay® at the prediabetes stage reduces the risk of developing type 2 diabetes.
Glucobay® has an excellent safety profile, is not associated with weight gain and is most efficacious when taken with healthy meals.
Glucobay® reduces the risk of developing diabetes to a similar extent as lifestyle modification, and this treatment is cost-effective.
Glucobay® is already approved as a treatment for prediabetes in more than 20 countries.
List of countries
Aruba
Bostwana
Brazil
China
Domincan Republic
Ecuador
El Salavador
Finland
Guatemala
Honduras
Hong Kong
India
Kenya
Mexico
Namibia
Nicaragua
Pakistan
Paraguay
Philippines
Portugal
South Africa
Thailand
Tanzania
Trinidad/Tobago
Turkey
Uganda
Venezuela
Bostwana
Brazil
China
Domincan Republic
Ecuador
El Salavador
Finland
Guatemala
Honduras
Hong Kong
India
Kenya
Mexico
Namibia
Nicaragua
Pakistan
Paraguay
Philippines
Portugal
South Africa
Thailand
Tanzania
Trinidad/Tobago
Turkey
Uganda
Venezuela
